Holen Sie sich die Stockscreener-App
3.98
1.02%
0.04
Handel nachbörslich:
3.98
Schlusskurs vom Vortag:
$3.94
Offen:
$3.94
24-Stunden-Volumen:
787.12K
Relative Volume:
0.64
Marktkapitalisierung:
$506.35M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-44.22
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
-4.56%
1M Leistung:
+3.65%
6M Leistung:
-7.66%
1J Leistung:
-23.90%
1-Tages-Spanne:
$3.845
$4.01
1-Wochen-Bereich:
$3.845
$4.20
52-Wochen-Spanne:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.98 | 511.44M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Custom strategy builders for tracking Cytek Biosciences Inc.Weekly Stock Analysis & Community Verified Trade Signals - Newser
Cytek Biosciences Inc. stock trend forecast2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
How to forecast Cytek Biosciences Inc. trends using time seriesJuly 2025 Recap & Fast Entry Momentum Alerts - Newser
Chart overlay techniques for tracking Cytek Biosciences Inc.2025 Pullback Review & Advanced Technical Analysis Signals - Newser
What institutional flow reveals about Cytek Biosciences Inc.July 2025 Action & Community Consensus Stock Picks - Newser
Relative strength of Cytek Biosciences Inc. in sector analysis2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
What is Cytek Biosciences Inc.’s valuation compared to sector2025 Market Outlook & Smart Investment Allocation Insights - khodrobank.com
How hedge fund analytics apply to Cytek Biosciences Inc. stock2025 Sector Review & Low Risk High Reward Ideas - Newser
What’s the recovery path for long term holders of Cytek Biosciences Inc.2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Momentum Shift: What is Cytek Biosciences Inc.’s valuation compared to sectorPrice Action & Community Verified Trade Signals - khodrobank.com
Is this a good reentry point in Cytek Biosciences Inc.2025 Earnings Impact & Capital Protection Trading Alerts - Newser
Is Cytek Biosciences Inc. reversing from oversold territoryMarket Risk Report & Community Trade Idea Sharing Platform - Newser
Identifying reversal signals in Cytek Biosciences Inc.2025 Market Outlook & Daily Stock Momentum Reports - Newser
Is Cytek Biosciences Inc. stock entering bullish territory2025 Dividend Review & Verified Entry Point Detection - Newser
How does Cytek Biosciences Inc. compare to its peersProfit Target & Weekly Top Gainers Trade List - khodrobank.com
Will Cytek Biosciences Inc. stock recover after earningsJuly 2025 Outlook & Daily Profit Focused Stock Screening - khodrobank.com
Will breakout in Cytek Biosciences Inc. lead to full recoveryJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Earnings visualization tools for Cytek Biosciences Inc.July 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Is Cytek Biosciences Inc. stock a good pick for beginners2025 Trade Ideas & Free Community Consensus Stock Picks - khodrobank.com
Is Cytek Biosciences Inc. a cyclical or defensive stock2025 Key Lessons & Growth Oriented Trading Recommendations - khodrobank.com
How sentiment analysis helps forecast Cytek Biosciences Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - Newser
Cytek Biosciences Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Cytek Biosciences Inc. currently under institutional pressure2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - خودرو بانک
Is Cytek Biosciences Inc. stock a buy or sellWeekly Loss Report & Low Volatility Stock Suggestions - khodrobank.com
Analyzing recovery setups for Cytek Biosciences Inc. investorsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Cytek Biosciences Inc. stock prediction for this weekWeekly Gains Report & Reliable Intraday Trade Plans - Newser
What is Cytek Biosciences Inc. s debt to equity ratioWeekly Gains Report & Weekly Watchlist of Top Performers - khodrobank.com
Cytek Biosciences Inc. stock volume spike explainedInflation Watch & Technical Pattern Based Buy Signals - Newser
Strategies to average down on Cytek Biosciences Inc.2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - Newser
Key metrics from Cytek Biosciences Inc.’s quarterly dataWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Applying Wyckoff theory to Cytek Biosciences Inc. stockJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Price action breakdown for Cytek Biosciences Inc.July 2025 Momentum & Community Consensus Picks - Newser
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):